bioAffinity Technologies, Inc. (NASDAQ: BIAFW) Stock Competitors & Peer Comparison
See BIAFW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BIAFW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BIAFW | $0.09 | +28.57% | 2.5M | 0.27 | $0.26 | N/A |
| ALC | $71.81 | +3.26% | 35B | 22.58 | $3.18 | +0.50% |
| STE | $237.47 | +2.45% | 23.2B | 22.80 | $10.42 | +1.06% |
| BRKRP | $400.35 | +2.91% | 8B | 217.58 | $1.84 | +0.38% |
| DRTSW | $3.40 | +4.13% | 1.3B | -5.26 | -$0.65 | N/A |
| SI | $20.59 | -8.20% | 427M | -10.75 | -$1.91 | N/A |
| MOBI | $12.24 | -0.65% | 407M | -0.65 | -$18.78 | N/A |
| MASS | $8.88 | +6.99% | 364.3M | -14.80 | -$0.60 | N/A |
| EDAP | $4.76 | -0.52% | 178.2M | -5.80 | -$0.82 | N/A |
| APYX | $4.05 | -2.64% | 170.5M | -18.41 | -$0.22 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
BIAFW vs ALC Comparison August 2026
bioAffinity Technologies, Inc. (NASDAQ: BIAFW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIAFW stands at 2.5M. In comparison, ALC has a market cap of 35B. Regarding current trading prices, BIAFW is priced at $0.09 on the NASDAQ, while ALC trades at $71.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIAFW currently has a P/E ratio of 0.27, whereas ALC's P/E ratio is 22.58. In terms of profitability, BIAFW's ROE is -2.57%, compared to ALC's ROE of +0.04%. Regarding short-term risk, BIAFW is less volatile compared to ALC. This indicates lower risk in terms of short-term price fluctuations for BIAFW.Check ALC's competition here
STERIS plc (NYSE: STE)
BIAFW vs STE Comparison August 2026
bioAffinity Technologies, Inc. (NASDAQ: BIAFW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIAFW stands at 2.5M. In comparison, STE has a market cap of 23.2B. Regarding current trading prices, BIAFW is priced at $0.09 on the NASDAQ, while STE trades at $237.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIAFW currently has a P/E ratio of 0.27, whereas STE's P/E ratio is 22.80. In terms of profitability, BIAFW's ROE is -2.57%, compared to STE's ROE of +0.11%. Regarding short-term risk, BIAFW is less volatile compared to STE. This indicates lower risk in terms of short-term price fluctuations for BIAFW.Check STE's competition here
Bruker Corporation (NASDAQ: BRKRP)
BIAFW vs BRKRP Comparison August 2026
bioAffinity Technologies, Inc. (NASDAQ: BIAFW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIAFW stands at 2.5M. In comparison, BRKRP has a market cap of 8B. Regarding current trading prices, BIAFW is priced at $0.09 on the NASDAQ, while BRKRP trades at $400.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIAFW currently has a P/E ratio of 0.27, whereas BRKRP's P/E ratio is 217.58. In terms of profitability, BIAFW's ROE is -2.57%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, BIAFW is less volatile compared to BRKRP. This indicates lower risk in terms of short-term price fluctuations for BIAFW.Check BRKRP's competition here
Alpha Tau Medical Ltd. (NASDAQ: DRTSW)
BIAFW vs DRTSW Comparison August 2026
bioAffinity Technologies, Inc. (NASDAQ: BIAFW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIAFW stands at 2.5M. In comparison, DRTSW has a market cap of 1.3B. Regarding current trading prices, BIAFW is priced at $0.09 on the NASDAQ, while DRTSW trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIAFW currently has a P/E ratio of 0.27, whereas DRTSW's P/E ratio is -5.26. In terms of profitability, BIAFW's ROE is -2.57%, compared to DRTSW's ROE of -0.73%. Regarding short-term risk, BIAFW is less volatile compared to DRTSW. This indicates lower risk in terms of short-term price fluctuations for BIAFW.Check DRTSW's competition here
Shoulder Innovations, Inc. (NYSE: SI)
BIAFW vs SI Comparison August 2026
bioAffinity Technologies, Inc. (NASDAQ: BIAFW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIAFW stands at 2.5M. In comparison, SI has a market cap of 427M. Regarding current trading prices, BIAFW is priced at $0.09 on the NASDAQ, while SI trades at $20.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIAFW currently has a P/E ratio of 0.27, whereas SI's P/E ratio is -10.75. In terms of profitability, BIAFW's ROE is -2.57%, compared to SI's ROE of -0.24%. Regarding short-term risk, BIAFW is less volatile compared to SI. This indicates lower risk in terms of short-term price fluctuations for BIAFW.Check SI's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
BIAFW vs MOBI Comparison August 2026
bioAffinity Technologies, Inc. (NASDAQ: BIAFW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIAFW stands at 2.5M. In comparison, MOBI has a market cap of 407M. Regarding current trading prices, BIAFW is priced at $0.09 on the NASDAQ, while MOBI trades at $12.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIAFW currently has a P/E ratio of 0.27, whereas MOBI's P/E ratio is -0.65. In terms of profitability, BIAFW's ROE is -2.57%, compared to MOBI's ROE of +0.31%. Regarding short-term risk, BIAFW is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for BIAFW.Check MOBI's competition here
908 Devices Inc. (NASDAQ: MASS)
BIAFW vs MASS Comparison August 2026
bioAffinity Technologies, Inc. (NASDAQ: BIAFW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIAFW stands at 2.5M. In comparison, MASS has a market cap of 364.3M. Regarding current trading prices, BIAFW is priced at $0.09 on the NASDAQ, while MASS trades at $8.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIAFW currently has a P/E ratio of 0.27, whereas MASS's P/E ratio is -14.80. In terms of profitability, BIAFW's ROE is -2.57%, compared to MASS's ROE of -0.26%. Regarding short-term risk, BIAFW is less volatile compared to MASS. This indicates lower risk in terms of short-term price fluctuations for BIAFW.Check MASS's competition here
Edap Tms S.a. (NASDAQ: EDAP)
BIAFW vs EDAP Comparison August 2026
bioAffinity Technologies, Inc. (NASDAQ: BIAFW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIAFW stands at 2.5M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, BIAFW is priced at $0.09 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIAFW currently has a P/E ratio of 0.27, whereas EDAP's P/E ratio is -5.80. In terms of profitability, BIAFW's ROE is -2.57%, compared to EDAP's ROE of -1.49%. Regarding short-term risk, BIAFW is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for BIAFW.Check EDAP's competition here
Apyx Medical Corporation (NASDAQ: APYX)
BIAFW vs APYX Comparison August 2026
bioAffinity Technologies, Inc. (NASDAQ: BIAFW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIAFW stands at 2.5M. In comparison, APYX has a market cap of 170.5M. Regarding current trading prices, BIAFW is priced at $0.09 on the NASDAQ, while APYX trades at $4.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIAFW currently has a P/E ratio of 0.27, whereas APYX's P/E ratio is -18.41. In terms of profitability, BIAFW's ROE is -2.57%, compared to APYX's ROE of -0.79%. Regarding short-term risk, BIAFW is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for BIAFW.Check APYX's competition here
Nyxoah S.A. (NASDAQ: NYXH)
BIAFW vs NYXH Comparison August 2026
bioAffinity Technologies, Inc. (NASDAQ: BIAFW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIAFW stands at 2.5M. In comparison, NYXH has a market cap of 58.2M. Regarding current trading prices, BIAFW is priced at $0.09 on the NASDAQ, while NYXH trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIAFW currently has a P/E ratio of 0.27, whereas NYXH's P/E ratio is -0.58. In terms of profitability, BIAFW's ROE is -2.57%, compared to NYXH's ROE of -1.64%. Regarding short-term risk, BIAFW is less volatile compared to NYXH. This indicates lower risk in terms of short-term price fluctuations for BIAFW.Check NYXH's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
BIAFW vs MDAI Comparison August 2026
bioAffinity Technologies, Inc. (NASDAQ: BIAFW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIAFW stands at 2.5M. In comparison, MDAI has a market cap of 55.7M. Regarding current trading prices, BIAFW is priced at $0.09 on the NASDAQ, while MDAI trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIAFW currently has a P/E ratio of 0.27, whereas MDAI's P/E ratio is -3.89. In terms of profitability, BIAFW's ROE is -2.57%, compared to MDAI's ROE of +1.79%. Regarding short-term risk, BIAFW is less volatile compared to MDAI. This indicates lower risk in terms of short-term price fluctuations for BIAFW.Check MDAI's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
BIAFW vs WOK Comparison August 2026
bioAffinity Technologies, Inc. (NASDAQ: BIAFW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIAFW stands at 2.5M. In comparison, WOK has a market cap of 5.1M. Regarding current trading prices, BIAFW is priced at $0.09 on the NASDAQ, while WOK trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIAFW currently has a P/E ratio of 0.27, whereas WOK's P/E ratio is N/A. In terms of profitability, BIAFW's ROE is -2.57%, compared to WOK's ROE of -0.07%. Regarding short-term risk, BIAFW is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for BIAFW.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
BIAFW vs QTEXW Comparison August 2026
bioAffinity Technologies, Inc. (NASDAQ: BIAFW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIAFW stands at 2.5M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, BIAFW is priced at $0.09 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIAFW currently has a P/E ratio of 0.27, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, BIAFW's ROE is -2.57%, compared to QTEXW's ROE of N/A. Regarding short-term risk, BIAFW is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for BIAFW.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
BIAFW vs ITOC Comparison August 2026
bioAffinity Technologies, Inc. (NASDAQ: BIAFW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIAFW stands at 2.5M. In comparison, ITOC has a market cap of 2.7M. Regarding current trading prices, BIAFW is priced at $0.09 on the NASDAQ, while ITOC trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIAFW currently has a P/E ratio of 0.27, whereas ITOC's P/E ratio is -0.93. In terms of profitability, BIAFW's ROE is -2.57%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, BIAFW is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for BIAFW.Check ITOC's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
BIAFW vs FEED Comparison August 2026
bioAffinity Technologies, Inc. (NASDAQ: BIAFW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIAFW stands at 2.5M. In comparison, FEED has a market cap of 434.6K. Regarding current trading prices, BIAFW is priced at $0.09 on the NASDAQ, while FEED trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIAFW currently has a P/E ratio of 0.27, whereas FEED's P/E ratio is -0.01. In terms of profitability, BIAFW's ROE is -2.57%, compared to FEED's ROE of -0.44%. Regarding short-term risk, BIAFW is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for BIAFW.Check FEED's competition here